- Home
- BNR vs SCOR Comparison
BNR vs SCOR Comparison
Compare BNR & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- SCOR
- Stock Information
- Founded
- BNR 2014
- SCOR 1999
- Country
- BNR China
- SCOR United States
- Employees
- BNR N/A
- SCOR N/A
- Industry
- BNR Medical Specialities
- SCOR Business Services
- Sector
- BNR Health Care
- SCOR Consumer Discretionary
- Exchange
- BNR Nasdaq
- SCOR Nasdaq
- Market Cap
- BNR 30.9M
- SCOR 27.7M
- IPO Year
- BNR 2020
- SCOR 2007
- Fundamental
- Price
- BNR $2.94
- SCOR $5.05
- Analyst Decision
- BNR
- SCOR Buy
- Analyst Count
- BNR 0
- SCOR 2
- Target Price
- BNR N/A
- SCOR $10.75
- AVG Volume (30 Days)
- BNR 20.3K
- SCOR 7.9K
- Earning Date
- BNR 05-28-2025
- SCOR 05-06-2025
- Dividend Yield
- BNR N/A
- SCOR N/A
- EPS Growth
- BNR N/A
- SCOR N/A
- EPS
- BNR N/A
- SCOR N/A
- Revenue
- BNR $70,669,261.00
- SCOR $356,047,000.00
- Revenue This Year
- BNR $136.32
- SCOR $4.38
- Revenue Next Year
- BNR N/A
- SCOR $3.97
- P/E Ratio
- BNR N/A
- SCOR N/A
- Revenue Growth
- BNR N/A
- SCOR N/A
- 52 Week Low
- BNR $2.62
- SCOR $4.59
- 52 Week High
- BNR $8.99
- SCOR $15.69
- Technical
- Relative Strength Index (RSI)
- BNR 24.38
- SCOR 36.26
- Support Level
- BNR $2.77
- SCOR $4.59
- Resistance Level
- BNR $3.29
- SCOR $5.63
- Average True Range (ATR)
- BNR 0.30
- SCOR 0.60
- MACD
- BNR 0.01
- SCOR -0.06
- Stochastic Oscillator
- BNR 13.82
- SCOR 25.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.